Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
08/15/2025 | CALL | $30.00 | 3 | +3 | |
07/18/2025 | CALL | $15.00 | 0 | 0 | |
07/18/2025 | CALL | $17.50 | 0 | 0 | |
07/18/2025 | CALL | $20.00 | 0 | 0 | |
07/18/2025 | CALL | $22.50 | 0 | 0 | |
07/18/2025 | CALL | $25.00 | 8 | 0 | |
12/19/2025 | PUT | $20.00 | 0 | 0 | |
12/19/2025 | PUT | $22.50 | 0 | 0 | |
12/19/2025 | PUT | $25.00 | 0 | 0 | |
12/19/2025 | PUT | $30.00 | 3 | 0 | |
12/19/2025 | PUT | $35.00 | 0 | 0 | |
12/19/2025 | PUT | $40.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Variable Insurance Products Fund-Growth Portfolio | 3.35% | 384.5k | 6.41M |
Fidelity Capital Appreciation Fund | 2.58% | 296k | 4.93M |
Fidelity Advisor Equity Growth Fund | 2.54% | 291.1k | 4.85M |
Vanguard Total Stock Market Index Fund | 1.94% | 222k | 3.7M |
Fidelity Growth Discovery Fund | 1.41% | 162.1k | 2.7M |
Vanguard Extended Market Index Fund | 0.60% | 68.35k | 1.14M |
Fidelity Advisor Series Equity Growth Fund | 0.49% | 55.68k | 928.13k |
Fidelity Select Portfolios - Pharmaceuticals | 0.47% | 53.3k | 888.51k |
Fidelity Extended Market Index Fund | 0.35% | 40.57k | 676.37k |
Avantis U.S. Small Cap Value ETF | 0.23% | 26.05k | 434.25k |
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX)
06/30 06:14 pm
GlobeNewswire Inc.
Read moreXOMA Royalty Declares Quarterly Preferred Stock Dividends
06/18 07:30 am
Benzinga
Read moreXOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
05/27 08:01 am
Benzinga
Read moreXOMA Royalty Declares Quarterly Preferred Stock Dividends
03/20 07:30 am
Benzinga
Read moreXOMA Royalty Declares Quarterly Preferred Stock Dividends
12/19 08:30 am
Benzinga
Read moreXOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
12/02 08:30 am
Benzinga
Read moreXOMA Corp to rebrand as XOMA Royalty Corporation By Investing.com - Investing.com
07/09 11:12 am
Investing.com
Read moreXoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
06/21 07:54 am
Zacks Investment Research
Read moreXOMA Declares Quarterly Preferred Stock Dividends
06/20 07:30 am
GlobeNewswire Inc.
Read morePeeling Back The Layers: Exploring XOMA Through Analyst Insights
05/31 08:00 am
Benzinga
Read moreXOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
05/14 07:30 am
GlobeNewswire Inc.
Read moreCertara, Inc. (CERT) Q1 Earnings Meet Estimates
05/07 06:40 pm
Zacks Investment Research
Read moreLexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
05/02 06:05 pm
Zacks Investment Research
Read moreXOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
04/30 07:30 am
GlobeNewswire Inc.
Read moreCracking The Code: Understanding Analyst Reviews For XOMA
04/29 10:00 am
Benzinga
Read moreXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
04/25 07:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at Upcoming Investor Conferences in March
02/28 08:30 am
GlobeNewswire Inc.
Read moreXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
01/18 09:30 am
GlobeNewswire Inc.
Read moreFDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
01/11 05:05 pm
GlobeNewswire Inc.
Read moreXOMA Announces Stock Repurchase Program of up to $50 Million
01/02 08:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
12/20 08:30 am
GlobeNewswire Inc.
Read moreI'm Buying Preferred Stocks Hand Over Fist
12/15 09:30 am
Seeking Alpha
Read moreXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
10/31 07:30 am
GlobeNewswire Inc.
Read moreRide The Royalty Ripple To Riches Like Charlie Munger
10/06 07:35 am
Seeking Alpha
Read moreXOMA Declares Quarterly Preferred Stock Dividends
09/25 07:30 am
GlobeNewswire Inc.
Read moreXoma (XOMA) Moves 7.7% Higher: Will This Strength Last?
09/18 12:41 pm
Zacks Investment Research
Read moreXOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference
09/06 07:30 am
GlobeNewswire Inc.
Read moreXOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
08/08 07:30 am
GlobeNewswire Inc.
Read moreCastle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
08/02 06:15 pm
Zacks Investment Research
Read moreXOMA Added to the Russell 2000® and Russell 3000® Indexes
06/23 06:14 pm
GlobeNewswire Inc.
Read moreArimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
06/22 03:09 pm
Benzinga
Read moreXOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset
06/22 07:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
06/20 07:30 am
GlobeNewswire Inc.
Read moreXOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
05/09 07:30 am
GlobeNewswire Inc.
Read moreStrength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?
04/28 03:28 am
Zacks Investment Research
Read moreXOMA to Present at H.C. Wainwright BioConnect Investor Conference
04/26 07:30 am
GlobeNewswire Inc.
Read moreXOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
03/30 07:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
03/21 07:30 am
GlobeNewswire Inc.
Read moreXOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
03/09 08:30 am
GlobeNewswire Inc.
Read moreXOMA to Present at 43rd Annual Cowen Health Care Conference
02/28 08:30 am
GlobeNewswire Inc.
Read moreXOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/06 08:00 pm
GlobeNewswire Inc.
Read moreNew Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
01/04 08:30 am
GlobeNewswire Inc.
Read moreXOMA Declares Quarterly Preferred Stock Dividends
12/22 08:30 am
GlobeNewswire Inc.
Read moreXOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon
11/22 08:01 am
GlobeNewswire Inc.
Read more